Stayble Therapeutics AB (publ) (STO:STABL)
0.2050
-0.0100 (-4.65%)
Inactive · Last trade price on Jun 2, 2026
Stayble Therapeutics AB Revenue
Stayble Therapeutics AB had revenue of 5.00K SEK in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to -17.00K.
Revenue (ttm)
-17.00K
Revenue Growth
n/a
P/S Ratio
-776.10
Revenue / Employee
-8.50K
Employees
2
Market Cap
13.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionStayble Therapeutics AB News
- 5 weeks ago - Stayble Therapeutics AB Quarterly report: Q1 2026 - Filings
- 4 months ago - Stayble Therapeutics AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Stayble Therapeutics AB Quarterly report: Q3 2025 - Filings
- 11 months ago - Stayble Therapeutics AB Quarterly report: Q2 2025 - Filings